CAMBRIDGE, England and COPENHAGEN, Denmark, Sept. 28, 2022 /PRNewswire/ — Vernalis Research (“Vernalis”), a fully owned subsidiary of HitGen Inc., …
OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced a peer-reviewed article published in …
Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced that its Senior Vice …
™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, today …
Cytovia Therapeutics, LLC, a global biotechnology company focused on harnessing the power of natural killer (NK) cells to fight cancer …
Tetra Bio-Pharma Inc a leader in cannabinoid-derived drug discovery and development today announced that the European Medicines Agency (EMA) has …
Neurocrine Biosciences, Inc. today announced its financial results for the first quarter ended March 31, 2022 and reiterated financial guidance …
Lytix Biopharma AS (Lytix), a clinical-stage company with an in situ vaccination technology platform targeting cancer indications, today announces that …
Pharming Group N.V. announces a change in its minority holding in BioConnection B.V, a contract development and manufacturing organization and …
Kim Meredith, CEO of the San Francisco General Hospital (SFGH) Foundation, has joined the advisory board of the UCSF Rosenman …
